304 related articles for article (PubMed ID: 27881053)
1. Oxytocin provides protection against diabetic polyneuropathy in rats.
Erbas O; Taşkıran D; Oltulu F; Yavaşoğlu A; Bora S; Bilge O; Çınar BP; Peker G
Neurol Res; 2017 Jan; 39(1):45-53. PubMed ID: 27881053
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of chronic administration of levetiracetam in a rat model of diabetic neuropathy.
Erbaş O; Oltulu F; Yılmaz M; Yavaşoğlu A; Taşkıran D
Diabetes Res Clin Pract; 2016 Apr; 114():106-16. PubMed ID: 26795972
[TBL] [Abstract][Full Text] [Related]
3. Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy.
Al-Rejaie SS; Aleisa AM; Abuohashish HM; Parmar MY; Ola MS; Al-Hosaini AA; Ahmed MM
Neurol Res; 2015 Oct; 37(10):924-33. PubMed ID: 26187552
[TBL] [Abstract][Full Text] [Related]
4. The preventive effect of oxytocin to Cisplatin-induced neurotoxicity: an experimental rat model.
Akman T; Akman L; Erbas O; Terek MC; Taskiran D; Ozsaran A
Biomed Res Int; 2015; 2015():167235. PubMed ID: 25688351
[TBL] [Abstract][Full Text] [Related]
5. Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with experimentally induced sepsis.
Erbaş O; Ergenoglu AM; Akdemir A; Yeniel AÖ; Taskiran D
J Surg Res; 2013 Jul; 183(1):313-20. PubMed ID: 23312812
[TBL] [Abstract][Full Text] [Related]
6. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
Obrosova IG; Fathallah L; Stevens MJ
Exp Neurol; 2001 Nov; 172(1):211-9. PubMed ID: 11681853
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of octreotide on diabetic neuropathy in rats.
Solmaz V; Çınar BP; Yiğittürk G; Özlece HK; Avni Eroglu H; Tekatas A; Erbaş O; Taşkıran D
Biomed Pharmacother; 2017 May; 89():468-472. PubMed ID: 28249248
[TBL] [Abstract][Full Text] [Related]
8. Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine.
Yalçın MB; Bora ES; Çakır A; Akbulut S; Erbaş O
Acta Cir Bras; 2023; 38():e387823. PubMed ID: 38055406
[TBL] [Abstract][Full Text] [Related]
9. "Adjusting internal organs and dredging channel" electroacupuncture treatment prevents the development of diabetic peripheral neuropathy by downregulating glucose-related protein 78 (GRP78) and caspase-12 in streptozotocin-diabetic rats.
Pan H; Huang H; Zhang L; Ma S; Yang H; Wang H
J Diabetes; 2019 Dec; 11(12):928-937. PubMed ID: 30884162
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of dental pulp stem cells improves long-term diabetic polyneuropathy together with improvement of nerve morphometrical evaluation.
Omi M; Hata M; Nakamura N; Miyabe M; Ozawa S; Nukada H; Tsukamoto M; Sango K; Himeno T; Kamiya H; Nakamura J; Takebe J; Matsubara T; Naruse K
Stem Cell Res Ther; 2017 Dec; 8(1):279. PubMed ID: 29237486
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of methanolic extract of Juglans regia L. leaf on streptozotocin-induced diabetic peripheral neuropathy in rats.
Nasiry D; Khalatbary AR; Ahmadvand H; Talebpour Amiri F; Akbari E
BMC Complement Altern Med; 2017 Oct; 17(1):476. PubMed ID: 28969623
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Tang Luo Ning effect on attenuating of oxidative stress in sciatic nerve of STZ-induced diabetic rats.
Yang X; Yao W; Li Q; Liu H; Shi H; Gao Y; Xu L
J Ethnopharmacol; 2015 Nov; 174():1-10. PubMed ID: 26254599
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of ferulic acid alone and in combination with insulin in streptozotocin induced diabetic neuropathy in Sprague Dawley rats.
Dhaliwal J; Dhaliwal N; Akhtar A; Kuhad A; Chopra K
Life Sci; 2020 Aug; 255():117856. PubMed ID: 32473246
[TBL] [Abstract][Full Text] [Related]
14. Zinc supplementation alleviates diabetic peripheral neuropathy by inhibiting oxidative stress and upregulating metallothionein in peripheral nerves of diabetic rats.
Liu F; Ma F; Kong G; Wu K; Deng Z; Wang H
Biol Trace Elem Res; 2014 May; 158(2):211-8. PubMed ID: 24615552
[TBL] [Abstract][Full Text] [Related]
15. GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats.
Ma J; Shi M; Zhang X; Liu X; Chen J; Zhang R; Wang X; Zhang H
Int J Mol Med; 2018 May; 41(5):2977-2985. PubMed ID: 29484377
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a rat model of type II diabetic neuropathic pain.
Dang JK; Wu Y; Cao H; Meng B; Huang CC; Chen G; Li J; Song XJ; Lian QQ
Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of folic acid on experimental diabetic peripheral neuropathy.
Yilmaz M; Aktug H; Oltulu F; Erbas O
Toxicol Ind Health; 2016 May; 32(5):832-40. PubMed ID: 24311627
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of gliclazide on diabetic peripheral neuropathy through Drp-1 mediated-oxidative stress and apoptosis.
Wu YB; Shi LL; Wu YJ; Xu WH; Wang L; Ren MS
Neurosci Lett; 2012 Aug; 523(1):45-9. PubMed ID: 22732450
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
[TBL] [Abstract][Full Text] [Related]
20. An early diagnostic tool for diabetic neuropathy: conduction velocity distribution.
Tuncer S; Dalkilic N; Esen HH; Avunduk MC
Muscle Nerve; 2011 Feb; 43(2):237-44. PubMed ID: 21254089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
